Efficacy and Safety of Injectable Semaglutide in Indian Patients with Type 2 Diabetes: Findings from a Phase III Study Presented at IDS 2026 Dr. Bhumika Maikhuri27 April 2026 11:00 AM ISTA recent Indian Phase III randomized open-label study has demonstrated that Sun Pharma's injectable semaglutide is non-inferior to international...
Common obesity medications lead to higher muscle loss than other weight loss interventions, review finds Dr. Kamal Kant Kohli26 April 2026 8:30 PM ISTA systematic review of clinical trials found that adults treated with incretin-based obesity medications, like semaglutide and tirzepatide, not only...
GLP-1 medicine improves liver health independent of weight loss, reveals research Dr. Kamal Kant Kohli24 April 2026 9:00 PM ISTResearchers at Toronto's Sinai Health have found that semaglutide-the active ingredient in popular weight loss drugs that mimic the gut hormone GLP-1...
SURMOUNT-5 Trial: Tirzepatide vs Semaglutide in Obesity Management Deeksha Bhandari20 April 2026 11:47 AM ISTThe SURMOUNT-5 trial evaluated the efficacy and safety of tirzepatide compared to semaglutide in adults with obesity or overweight with at least one...
No Ads for Prescription Drugs: Panel Flags Surrogate Advertising, Misleading Promotions of GLP-1 Obesity Drugs Susmita Roy18 April 2026 8:51 PM ISTNew Delhi: The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and enforcement against...
Hetero Targets 1.5 Million Semaglutide Pens, Eyes 75+ Markets sheeba farhat16 April 2026 8:30 PM ISTHyderabad: Hetero Labs, one of India's largest privately held drugmakers, aims to sell 1.5 ​million pens of generic weight-loss and diabetes drugs in...
AIIMS Expert Warns Semaglutide Cannot Replace Lifestyle Changes Anshika Mishra13 April 2026 5:51 PM ISTA doctor from the All India Institute of Medical Sciences has cautioned that lifestyle changes cannot be replaced by Semaglutide, highlighting growing...
Health Bulletin 13/April/2026 Anshika Mishra13 April 2026 5:49 PM ISTHere are the top health stories for the day:NBE Releases Tentative 2026 Exam Schedule for FMGE, DNB, DrNB and Diploma CoursesThe National Board of...
Wegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US Market MD Bureau8 April 2026 7:10 PM ISTBengaluru: Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United...
Emcure Pharma Cuts Poviztra Price by 55%, Starting Dose Now Rs 3,999 per Month Parthika Patel4 April 2026 2:25 PM ISTNew Delhi: Emcure Pharmaceuticals Limited has announced a major price reduction of up to 55% for the starting dose of its weight management drug...
Semaglutide Improves Walking Capacity in Peripheral Artery Disease: STRIDE Trial Dr Riya Dave3 April 2026 10:00 AM ISTResearchers have found in the STRIDE trial that semaglutide significantly improved walking capacity in patients with peripheral artery disease (PAD)....
Hetero Launches Generic Semaglutide Brands Truglyx, Rolmodl, Moto G Across 75+ Countries sheeba farhat28 March 2026 8:22 PM ISTNew Delhi: Hetero has announced the export launch of its generic semaglutide portfolio, marking a significant step toward expanding access to GLP-1...
